HRMY logo

HARMONY BIOSCIENCES HOLDINGS

HRMYNASDAQ
πŸ† #1848 by market capUS Equity
β€”β€”
Quote unavailable
πŸ””
Track HRMY
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$1.91B
Small Cap
πŸ“ˆRevenue Growth (YoY)
19.8%
Healthy
πŸ“ŠGross Margin
74.0%
High
πŸ’΅FCF Margin
30.7%
Strong
βš–οΈP/S Ratio
1.9x
Cheap
Otter Score
76
Strong
No chart data available for HRMY.

Trading Snapshot

Day Range
β€”
52-Week Range
$25.90 – $43.49
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
58.2M
Next Earnings
β€”

Fundamentals Snapshot

Annual Revenue
$868M
Last Q Revenue
$269M
P/E Ratio
10.7
P/S Ratio
1.9x
EPS (TTM)
$3.03
Dividend Yield
β€”
Dilution (1yr)
+0.8%
HRMY logo

HARMONY BIOSCIENCES HOLDINGS

HRMY
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$868Mβ–² +21.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
77.2%β–Ό βˆ’1.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$208Mβ–² +9.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$348Mβ–² +59.1% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
58.7Mβ–² +0.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$513Mβ–² +$241M YoY
StockOtter Β· stockotter.space

About HARMONY BIOSCIENCES HOLDINGS

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc. before adopting its current name in February 2020. Harmony Biosciences Holdings, Inc. operates out of Plymouth Meeting, Pennsylvania.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
76/100
Analyst data unavailable.

Latest News & Updates

News unavailable.